FDAzilla mentioned on front-page WSJ story

 

FDAzilla was mentioned in a front-page story today in the Wall Street Journal.  The article mirrors a key theme that we’ve talked about here – that the investment community is becoming more and more interested in FDA 483s, FDA inspections, and other government data.

Current and potential investors of your company may actually be reading your FDA 483.

Read the whole article here>>

Other 483 Resources

Learn more about how FDAzilla can help you achieve your quality and inspection preparation goals: get 483sInspector ProfilesEnforcement Analytics, and GMP Regulatory Intelligence.

SUBSCRIBE TO OUR MONTHLY NEWSLETTER>>

Leave a Reply

Your email address will not be published. Required fields are marked *